KEKLİK KARADAĞ, F. Et Al. 2019. Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey. 101.RED CELLS AND ERYTHROPOIESIS, STRUCTURE AND FUNCTION, METABOLISM, AND SURVIVAL, EXCLUDING IRON NOVEMBER 13, 2019 , 4805.

KEKLİK KARADAĞ, F., YENEREL, M. N., YILMAZ, M., ÜSKÜDAR TEKE, H., ÖZKOCAMAN, V., TUĞLULAR, A. T., ... ERDEM, F.(2019). Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey . 101.RED CELLS AND ERYTHROPOIESIS, STRUCTURE AND FUNCTION, METABOLISM, AND SURVIVAL, EXCLUDING IRON NOVEMBER 13, 2019 (pp.4805).

KEKLİK KARADAĞ, FATMA Et Al. "Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey," 101.RED CELLS AND ERYTHROPOIESIS, STRUCTURE AND FUNCTION, METABOLISM, AND SURVIVAL, EXCLUDING IRON NOVEMBER 13, 2019, 2019

KEKLİK KARADAĞ, FATMA K. Et Al. "Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey." 101.RED CELLS AND ERYTHROPOIESIS, STRUCTURE AND FUNCTION, METABOLISM, AND SURVIVAL, EXCLUDING IRON NOVEMBER 13, 2019 , pp.4805, 2019

KEKLİK KARADAĞ, F. Et Al. (2019) . "Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey." 101.RED CELLS AND ERYTHROPOIESIS, STRUCTURE AND FUNCTION, METABOLISM, AND SURVIVAL, EXCLUDING IRON NOVEMBER 13, 2019 , p.4805.

@conferencepaper{conferencepaper, author={FATMA KEKLİK KARADAĞ Et Al. }, title={Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey}, congress name={101.RED CELLS AND ERYTHROPOIESIS, STRUCTURE AND FUNCTION, METABOLISM, AND SURVIVAL, EXCLUDING IRON NOVEMBER 13, 2019}, city={}, country={}, year={2019}, pages={4805} }